Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...

Global Times: Key meeting maps out plan for China’s economic work in 2026

China’s 2026 economic agenda centers on boosting demand, innovation and opening-up, strengthening confidence amid global uncertainty.Beijing, China, Dec. 15, 2025 (GLOBE NEWSWIRE) -- China will ...